Drug Interactions With Direct-Acting Antivirals for Hepatitis C

Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects.

(2017) P. Badri et al.   TRANSPLANTATION

Sofosbuvir

(2014) Lucia Rose et al.   ANNALS OF PHARMACOTHERAPY

O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY

(2014) N. Afdhal et al.   JOURNAL OF HEPATOLOGY

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

(2014) Paul Y. Kwo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-liver transplant hepatitis C virus recurrence: An unresolved thorny problem

(2014) Alberto Grassi   WORLD JOURNAL OF GASTROENTEROLOGY

The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

(2013) Kathleen N. Ly et al.   ANNALS OF INTERNAL MEDICINE

Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.

(2013) Marc Bifano et al.   ANTIVIRAL THERAPY

887 PHARMACOKINETICS OF SIMEPREVIR (TMC435) IN VOLUNTEERS WITH MODERATE OR SEVERE HEPATIC IMPAIRMENT

(2013) S. Ouwerkerk-Mahadevan et al.   JOURNAL OF HEPATOLOGY

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

(2013) Christophe Hézode et al.   JOURNAL OF HEPATOLOGY

1130 THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-7977 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS

(2012) E. Lawitz et al.   JOURNAL OF HEPATOLOGY

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

(2010) J B Dumond et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

(2009) Caroline Barau et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Induction Effects of Ritonavir: Implications for Drug Interactions

(2008) Michelle M Foisy et al.   ANNALS OF PHARMACOTHERAPY

The Challenge of Hepatitis C in the HIV-Infected Person

(2008) David L. Thomas   Annual Review of Medicine

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

(2008) Shu-Feng Zhou   CURRENT DRUG METABOLISM

HIV and hepatitis C coinfection

(2008) Gail V Matthews et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY